img

Global MSD Treatment Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global MSD Treatment Market Research Report 2024

Musculoskeletal Disorders or MSDs are injuries anddisorders that affect the human body's movement ormusculoskeletal system (i.e. muscles, tendons, ligaments, nerves, discs, blood vessels, etc.). Common MSDs includeCarpal Tunnel Syndrome. Tendonitis. Muscle / Tendon 
According to MRAResearch’s new survey, global MSD Treatment market is projected to reach US$ 110750 million in 2033, increasing from US$ 82410 million in 2022, with the CAGR of 4.2% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole MSD Treatment market research.
The Musculoskeletal Disorders Drugs market refers to the pharmaceuticals and medications used for the treatment of disorders and diseases related to the musculoskeletal system, including arthritis, osteoporosis, and musculoskeletal pain. This market encompasses various therapeutic areas such as nonsteroidal anti-inflammatory drugs (NSAIDs), analgesics, disease-modifying antirheumatic drugs (DMARDs), and bone health medications. The Musculoskeletal Disorders Drugs market has been witnessing steady growth due to factors such as the aging population, increasing prevalence of musculoskeletal disorders, and advancements in drug development. Key players in the market include pharmaceutical companies, biotechnology firms, and generic drug manufacturers. Geographically, North America holds a significant market share, followed by Europe. However, the market in Asia Pacific is expected to witness substantial growth in the coming years, driven by the rising incidence of musculoskeletal disorders and improving access to healthcare.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global MSD Treatment market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


AbbVie
Amgen
Johnson & Johnson
Roche
Pfizer Inc
Eli Lilly
Merck
Novartis
UCB
Segment by Type
OTC
Rx Drugs

Segment by Application


Hospital
Retail Pharmacy
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The MSD Treatment report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global MSD Treatment Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 OTC
1.2.3 Rx Drugs
1.3 Market by Application
1.3.1 Global MSD Treatment Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global MSD Treatment Market Perspective (2018-2033)
2.2 MSD Treatment Growth Trends by Region
2.2.1 Global MSD Treatment Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 MSD Treatment Historic Market Size by Region (2018-2023)
2.2.3 MSD Treatment Forecasted Market Size by Region (2024-2033)
2.3 MSD Treatment Market Dynamics
2.3.1 MSD Treatment Industry Trends
2.3.2 MSD Treatment Market Drivers
2.3.3 MSD Treatment Market Challenges
2.3.4 MSD Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top MSD Treatment Players by Revenue
3.1.1 Global Top MSD Treatment Players by Revenue (2018-2023)
3.1.2 Global MSD Treatment Revenue Market Share by Players (2018-2023)
3.2 Global MSD Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by MSD Treatment Revenue
3.4 Global MSD Treatment Market Concentration Ratio
3.4.1 Global MSD Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by MSD Treatment Revenue in 2022
3.5 MSD Treatment Key Players Head office and Area Served
3.6 Key Players MSD Treatment Product Solution and Service
3.7 Date of Enter into MSD Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 MSD Treatment Breakdown Data by Type
4.1 Global MSD Treatment Historic Market Size by Type (2018-2023)
4.2 Global MSD Treatment Forecasted Market Size by Type (2024-2033)
5 MSD Treatment Breakdown Data by Application
5.1 Global MSD Treatment Historic Market Size by Application (2018-2023)
5.2 Global MSD Treatment Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America MSD Treatment Market Size (2018-2033)
6.2 North America MSD Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America MSD Treatment Market Size by Country (2018-2023)
6.4 North America MSD Treatment Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe MSD Treatment Market Size (2018-2033)
7.2 Europe MSD Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe MSD Treatment Market Size by Country (2018-2023)
7.4 Europe MSD Treatment Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific MSD Treatment Market Size (2018-2033)
8.2 Asia-Pacific MSD Treatment Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific MSD Treatment Market Size by Region (2018-2023)
8.4 Asia-Pacific MSD Treatment Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America MSD Treatment Market Size (2018-2033)
9.2 Latin America MSD Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America MSD Treatment Market Size by Country (2018-2023)
9.4 Latin America MSD Treatment Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa MSD Treatment Market Size (2018-2033)
10.2 Middle East & Africa MSD Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa MSD Treatment Market Size by Country (2018-2023)
10.4 Middle East & Africa MSD Treatment Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AbbVie
11.1.1 AbbVie Company Detail
11.1.2 AbbVie Business Overview
11.1.3 AbbVie MSD Treatment Introduction
11.1.4 AbbVie Revenue in MSD Treatment Business (2018-2023)
11.1.5 AbbVie Recent Development
11.2 Amgen
11.2.1 Amgen Company Detail
11.2.2 Amgen Business Overview
11.2.3 Amgen MSD Treatment Introduction
11.2.4 Amgen Revenue in MSD Treatment Business (2018-2023)
11.2.5 Amgen Recent Development
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Company Detail
11.3.2 Johnson & Johnson Business Overview
11.3.3 Johnson & Johnson MSD Treatment Introduction
11.3.4 Johnson & Johnson Revenue in MSD Treatment Business (2018-2023)
11.3.5 Johnson & Johnson Recent Development
11.4 Roche
11.4.1 Roche Company Detail
11.4.2 Roche Business Overview
11.4.3 Roche MSD Treatment Introduction
11.4.4 Roche Revenue in MSD Treatment Business (2018-2023)
11.4.5 Roche Recent Development
11.5 Pfizer Inc
11.5.1 Pfizer Inc Company Detail
11.5.2 Pfizer Inc Business Overview
11.5.3 Pfizer Inc MSD Treatment Introduction
11.5.4 Pfizer Inc Revenue in MSD Treatment Business (2018-2023)
11.5.5 Pfizer Inc Recent Development
11.6 Eli Lilly
11.6.1 Eli Lilly Company Detail
11.6.2 Eli Lilly Business Overview
11.6.3 Eli Lilly MSD Treatment Introduction
11.6.4 Eli Lilly Revenue in MSD Treatment Business (2018-2023)
11.6.5 Eli Lilly Recent Development
11.7 Merck
11.7.1 Merck Company Detail
11.7.2 Merck Business Overview
11.7.3 Merck MSD Treatment Introduction
11.7.4 Merck Revenue in MSD Treatment Business (2018-2023)
11.7.5 Merck Recent Development
11.8 Novartis
11.8.1 Novartis Company Detail
11.8.2 Novartis Business Overview
11.8.3 Novartis MSD Treatment Introduction
11.8.4 Novartis Revenue in MSD Treatment Business (2018-2023)
11.8.5 Novartis Recent Development
11.9 UCB
11.9.1 UCB Company Detail
11.9.2 UCB Business Overview
11.9.3 UCB MSD Treatment Introduction
11.9.4 UCB Revenue in MSD Treatment Business (2018-2023)
11.9.5 UCB Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global MSD Treatment Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of OTC
Table 3. Key Players of Rx Drugs
Table 4. Global MSD Treatment Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 5. Global MSD Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global MSD Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global MSD Treatment Market Share by Region (2018-2023)
Table 8. Global MSD Treatment Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 9. Global MSD Treatment Market Share by Region (2024-2033)
Table 10. MSD Treatment Market Trends
Table 11. MSD Treatment Market Drivers
Table 12. MSD Treatment Market Challenges
Table 13. MSD Treatment Market Restraints
Table 14. Global MSD Treatment Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global MSD Treatment Market Share by Players (2018-2023)
Table 16. Global Top MSD Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in MSD Treatment as of 2022)
Table 17. Ranking of Global Top MSD Treatment Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by MSD Treatment Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players MSD Treatment Product Solution and Service
Table 21. Date of Enter into MSD Treatment Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global MSD Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global MSD Treatment Revenue Market Share by Type (2018-2023)
Table 25. Global MSD Treatment Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 26. Global MSD Treatment Revenue Market Share by Type (2024-2033)
Table 27. Global MSD Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global MSD Treatment Revenue Market Share by Application (2018-2023)
Table 29. Global MSD Treatment Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 30. Global MSD Treatment Revenue Market Share by Application (2024-2033)
Table 31. North America MSD Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 32. North America MSD Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America MSD Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 34. Europe MSD Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 35. Europe MSD Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe MSD Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 37. Asia-Pacific MSD Treatment Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 38. Asia-Pacific MSD Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific MSD Treatment Market Size by Region (2024-2033) & (US$ Million)
Table 40. Latin America MSD Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 41. Latin America MSD Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America MSD Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 43. Middle East & Africa MSD Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Middle East & Africa MSD Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa MSD Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 46. AbbVie Company Detail
Table 47. AbbVie Business Overview
Table 48. AbbVie MSD Treatment Product
Table 49. AbbVie Revenue in MSD Treatment Business (2018-2023) & (US$ Million)
Table 50. AbbVie Recent Development
Table 51. Amgen Company Detail
Table 52. Amgen Business Overview
Table 53. Amgen MSD Treatment Product
Table 54. Amgen Revenue in MSD Treatment Business (2018-2023) & (US$ Million)
Table 55. Amgen Recent Development
Table 56. Johnson & Johnson Company Detail
Table 57. Johnson & Johnson Business Overview
Table 58. Johnson & Johnson MSD Treatment Product
Table 59. Johnson & Johnson Revenue in MSD Treatment Business (2018-2023) & (US$ Million)
Table 60. Johnson & Johnson Recent Development
Table 61. Roche Company Detail
Table 62. Roche Business Overview
Table 63. Roche MSD Treatment Product
Table 64. Roche Revenue in MSD Treatment Business (2018-2023) & (US$ Million)
Table 65. Roche Recent Development
Table 66. Pfizer Inc Company Detail
Table 67. Pfizer Inc Business Overview
Table 68. Pfizer Inc MSD Treatment Product
Table 69. Pfizer Inc Revenue in MSD Treatment Business (2018-2023) & (US$ Million)
Table 70. Pfizer Inc Recent Development
Table 71. Eli Lilly Company Detail
Table 72. Eli Lilly Business Overview
Table 73. Eli Lilly MSD Treatment Product
Table 74. Eli Lilly Revenue in MSD Treatment Business (2018-2023) & (US$ Million)
Table 75. Eli Lilly Recent Development
Table 76. Merck Company Detail
Table 77. Merck Business Overview
Table 78. Merck MSD Treatment Product
Table 79. Merck Revenue in MSD Treatment Business (2018-2023) & (US$ Million)
Table 80. Merck Recent Development
Table 81. Novartis Company Detail
Table 82. Novartis Business Overview
Table 83. Novartis MSD Treatment Product
Table 84. Novartis Revenue in MSD Treatment Business (2018-2023) & (US$ Million)
Table 85. Novartis Recent Development
Table 86. UCB Company Detail
Table 87. UCB Business Overview
Table 88. UCB MSD Treatment Product
Table 89. UCB Revenue in MSD Treatment Business (2018-2023) & (US$ Million)
Table 90. UCB Recent Development
Table 91. Research Programs/Design for This Report
Table 92. Key Data Information from Secondary Sources
Table 93. Key Data Information from Primary Sources
List of Figures
Figure 1. Global MSD Treatment Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global MSD Treatment Market Share by Type: 2022 VS 2033
Figure 3. OTC Features
Figure 4. Rx Drugs Features
Figure 5. Global MSD Treatment Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 6. Global MSD Treatment Market Share by Application: 2022 VS 2033
Figure 7. Hospital Case Studies
Figure 8. Retail Pharmacy Case Studies
Figure 9. MSD Treatment Report Years Considered
Figure 10. Global MSD Treatment Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 11. Global MSD Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 12. Global MSD Treatment Market Share by Region: 2022 VS 2033
Figure 13. Global MSD Treatment Market Share by Players in 2022
Figure 14. Global Top MSD Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in MSD Treatment as of 2022)
Figure 15. The Top 10 and 5 Players Market Share by MSD Treatment Revenue in 2022
Figure 16. North America MSD Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 17. North America MSD Treatment Market Share by Country (2018-2033)
Figure 18. United States MSD Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 19. Canada MSD Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. Europe MSD Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Europe MSD Treatment Market Share by Country (2018-2033)
Figure 22. Germany MSD Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. France MSD Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. U.K. MSD Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. Italy MSD Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Russia MSD Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Nordic Countries MSD Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Asia-Pacific MSD Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Asia-Pacific MSD Treatment Market Share by Region (2018-2033)
Figure 30. China MSD Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Japan MSD Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. South Korea MSD Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Southeast Asia MSD Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. India MSD Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Australia MSD Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Latin America MSD Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Latin America MSD Treatment Market Share by Country (2018-2033)
Figure 38. Mexico MSD Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Brazil MSD Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Middle East & Africa MSD Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Middle East & Africa MSD Treatment Market Share by Country (2018-2033)
Figure 42. Turkey MSD Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Saudi Arabia MSD Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. AbbVie Revenue Growth Rate in MSD Treatment Business (2018-2023)
Figure 45. Amgen Revenue Growth Rate in MSD Treatment Business (2018-2023)
Figure 46. Johnson & Johnson Revenue Growth Rate in MSD Treatment Business (2018-2023)
Figure 47. Roche Revenue Growth Rate in MSD Treatment Business (2018-2023)
Figure 48. Pfizer Inc Revenue Growth Rate in MSD Treatment Business (2018-2023)
Figure 49. Eli Lilly Revenue Growth Rate in MSD Treatment Business (2018-2023)
Figure 50. Merck Revenue Growth Rate in MSD Treatment Business (2018-2023)
Figure 51. Novartis Revenue Growth Rate in MSD Treatment Business (2018-2023)
Figure 52. UCB Revenue Growth Rate in MSD Treatment Business (2018-2023)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed